​

Lantern Pharma (LTRN) Revenue & Revenue Breakdown

OverviewOwnershipFinancialsChartTranscripts

Lantern Pharma Revenue Highlights

00

Lantern Pharma Revenue by Period

Lantern Pharma Revenue by Year

DateRevenueChange
2024-12-31-100.00%
2023-12-31-100.00%
2022-12-31-100.00%
2021-12-31-100.00%
2020-12-31-100.00%
2019-12-31-100.00%
2018-12-31--

Lantern Pharma generated - in revenue during NA 2024, up 100.00% compared to the previous quarter, and up NaN% compared to the same period a year ago.

Lantern Pharma Revenue by Quarter

DateRevenueChange
2025-09-30-100.00%
2025-06-30-100.00%
2025-03-31--100.00%
2024-12-31$100.65K100.00%
2024-09-30-100.00%
2024-06-30-100.00%
2024-03-31--100.00%
2023-12-31$261.05K100.00%
2023-09-30-100.00%
2023-06-30-100.00%
2023-03-31-100.00%
2022-12-31-100.00%
2022-09-30-100.00%
2022-06-30-100.00%
2022-03-31-100.00%
2021-12-31-100.00%
2021-09-30-100.00%
2021-06-30-100.00%
2021-03-31-100.00%
2020-12-31-100.00%
2020-09-30-100.00%
2020-06-30-100.00%
2020-03-31-100.00%
2019-12-31-100.00%
2019-09-30-100.00%
2019-06-30-100.00%
2019-03-31--

Lantern Pharma generated - in revenue during Q3 2025, up 100.00% compared to the previous quarter, and up NaN% compared to the same period a year ago.

Lantern Pharma Peer Comparison by Revenue

TickerCompanyLast Year RevenueLast Quarter Revenue
ELUTElutia$24.38M$3.32M
LVTXLAVA Therapeutics$11.98M-
RNXTRenovoRx$43.00K$266.00K
LTRNLantern Pharma--
RVPHReviva Pharmaceuticals--
BCABBioAtla--
CALCCalciMedica--
TVRDTvardi Therapeutics--
ANVSAnnovis Bio--

LTRN Revenue FAQ

What is Lantern Pharma’s yearly revenue?

Lantern Pharma's yearly revenue for 2024 was $0, representing an increase of 100.00% compared to 2023. The company's yearly revenue for 2023 was $0, representing an increase of 100.00% compared to 2022. LTRN's yearly revenue for 2022 was $0, representing an increase of 100.00% compared to 2021.

What is Lantern Pharma’s quarterly revenue?

Lantern Pharma's quarterly revenue for Q3 2025 was $0, a 100.00% increase from the previous quarter (Q2 2025), and a 0% increase year-over-year (Q3 2024). The company's quarterly revenue for Q2 2025 was $0, a 100.00% increase from the previous quarter (Q1 2025), and a 0% increase year-over-year (Q2 2024). LTRN's quarterly revenue for Q1 2025 was $0, a -100.00% decrease from the previous quarter (Q4 2024), and a 0% increase year-over-year (Q1 2024).

What is Lantern Pharma’s revenue growth rate?

Lantern Pharma's revenue growth rate for the last 3 years (2022-2024) was 0%, and for the last 5 years (2020-2024) was 0%.